From bench to bedside: elucidating VEGF(R) inhibitor-related heart failure in cancer treatment
Abstract Background Vascular endothelial growth factor (VEGF) and VEGF receptor (VEGFR) inhibitors play a pivotal role in treating various tumors; however, the clinical characteristics and molecular mechanisms of their associated heart failure (HF) remain incompletely understood. Methods We investig...
Saved in:
Main Authors: | Shengkun Peng, MinHong Cai, Hongyu Kuang, Anqi Lin, Qinghua Ma, Xiaoqin Dai, Peng Luo, Yijun Liu, Guo Zhang, Yifeng Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-025-06133-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the Molecular Modalities in the Pathogenesis of Diabetic Kidney Disease with a Focus on the Potential Therapeutic Implications
by: Lyubomir Gaydarski, et al.
Published: (2024-12-01) -
Anti-inflammatory and immunomodulatory effects of rosuvastatin in patients with low-to-moderate cardiovascular risk
by: VAVLUKIS ANA, et al.
Published: (2022-06-01) -
A structural model of the VEGF signalling pathway: Emergence of robustness and redundancy properties
by: Floriane Lignet, et al.
Published: (2012-11-01) -
Vascular endothelial growth factor and endocan expression in adrenal cortical tumors and their relationship with histopathological prognostic parameters
by: Melia Karaköse, et al.
Published: (2024-08-01) -
Pathogenetic mechanism of stented coronary arteries restenosis and the role of vasculoendothelial growth factor A
by: M.P. Kopytsya, et al.
Published: (2019-10-01)